We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Abbott Laboratories | LSE:0Q15 | London | Ordinary Share | ABBOTT LABORATORIES ORD (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 57.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 2,218 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 40.11B | 5.72B | 3.2965 | 38.81 | 98.96B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 01/11/2024 | 10:11 | ALNC |  EXTRA: Reckitt infant formula US legal boost is "best case scenario" |
| 01/11/2024 | 08:56 | ALNC | TOP NEWS: Shares in Reckitt Benckiser leap amid Mead Johnson legal win |
| 29/7/2024 | 08:40 | ALNC | REPEAT: Abbott jury award could dash Reckitt's plans to sell Mead |
| 29/7/2024 | 08:10 | ALNC | TOP NEWS: Abbot jury award could dash Reckitt's plans to sell Mead |
1 Year Abbott Laboratories Chart |
Intraday Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
